May
Medicinal Chemistry
&
Drug Discovery Biology
Strategy Meeting East Coast USA 2025
Reinvigorating Productivity in Pharma and Biotech R&D Through Advanced Technologies and Innovative Techniques that Interrogate Activity and Mechanisms
days
hours
minutes
seconds
What makes our strategy meetings unique?

Roundtable Discussions
Intimate discussions led by renowned industry experts. Have your voice heard and debate alongside like-minded life science executives.

Unrivalled Networking
With senior delegation from big pharma and innovative biotech from across the East Coast, you can network with peers from different locations, all in one place.

Personalised Agenda
Choose the topics that matter to you. Reserve your place at the roundtable discussions and ensure your whole day delivers the insights you need to hear.

Solutions to your Problems
We've partnered with the best solution providers to solve your biggest challenges. Engage in pre-arranged, private meetings to address your specific needs and find a tangible solution.

Industry Researched Topics
We guarantee our agenda is up-to-date and mission critical because its designed by you. We speak to our extended network of senior decision makers to ensure the most important topics are discussed.

Senior Decision Makers
The entire strategy meeting is specifically tailored to the needs and challenges of senior life science professionals. Discover how your peers are dealing with the same challenges as you.
Our Facilitators
Our panel of facilitators play a key role in shaping the agenda for the day. See who will be bringing their expertise to the table at our Medicinal Chemistry strategy meeting..

Abhijat Vatsyayan
Head of Artificial Intelligence Taiho Oncology
Dongming Shen
Vice President, Chemistry Viva Star Biosciences
Frank Yocca
Senior Vice President and Chief Scientific Officer BioXcel Therapeutics
Gunaretnam Rajagopal
Venture Partner Samsara Biocapital
Gurdyal Kalsi
Chief Medical Officer Asklepion Pharmaceuticals LLC
Herve Aloysius
Head of DMPK BioCryst Pharmaceuticals
Huijun Wang
Head of Computational Drug Design Deerfield Management
Joshi Ramanjulu
Chief Scientific Officer Apogee Pharmaceuticals
Marcie Glicksman
Vice President, Biology Enclear Therapies
Nikolaos Tezapsidis
President & CEO Neurotez Inc.
Rahul Mittal
Head Strategy and Innovation- North America Dr. Reddy’s Laboratories
Rui Wu
Senior Vice President,Head of Research & Preclinical and ChiefCMC Officer Graviton Bioscience
Sekhar Surapaneni
Executive Director, DMPK Nimbus Therapeutics
Sesha Kumar
Vice President & Head Intellectual Property, Innovation Dr. Reddy’s
Shah Nawaz
Chief Technology Officer and Vice President, Digital Technology & Engineering Regeneron
Tanweer Khan
Senior Director, Head of Discovery Chemistry aTai Life Sciences
Vikram Sinha
Global Head, Therapeutic Areas NIBR
Zhihua Sui
Chief Scientific Officer SK Life ScienceOur Agenda
See Which Topics Are Discussed at the Strategy Meeting
Roundtable Tracks
1Revolutionizing Drug Discovery: Unleashing AI and Generative Modeling for Molecular Innovation (Topic TBC)
-Abhijat Vatsyayan
Head of Artificial Intelligence
Taiho Oncology
DMPK / ADME & Toxicology
Bridging Preclinical Models and Human Safety: Innovations in DMPK and Toxicology (Topic TBC)
-Dongming Shen
Vice President, Chemistry
Viva Star Biosciences
Chemical Biology, Targeted Protein Degradation And Undruggables
Beyond the Degradation Mechanism: Addressing Safety and Formulation in Targeted Therapeutics
-Zhihua Sui
Chief Scientific Officer
SK Life Science
Target Identification To Lead Optimization
Innovative Approaches to Lead Optimization: Integrating Computational Methods and Machine Learning in Small Molecule Design (Topic TBC)
-Huijun Wang
Head of Computational Drug Design
Deerfield Management
Strategic Partnerships In Drug Discovery
Strategic Alliances and Investment Strategies: Fueling the Future of Drug Discovery
-Nikolaos Tezapsidis
President & CEO
Neurotez Inc.
Integrated Drug Discovery
What Are the Key Challenges in Integrating RNA-Based Therapies into the Drug Discovery Pipeline? (Topic TBC)
-Frank Yocca
Senior Vice President and Chief Scientific Officer
BioXcel Therapeutics
Roundtable Tracks
2Emerging Challenges in Machine Learning (ML) -Driven Molecular Property Predictions
Sponsor
DMPK / ADME & ToxicologyOptimizing Drug Development through Pharmacokinetic Prediction for Enhanced Drug Efficacy
Sponsor
Chemical Biology, Targeted Protein Degradation And UndruggablesChemoproteomics: Probing Small Molecules’ Interactions with Complex Biological Systems
Sponsor
Target Identification To Lead OptimizationFragment Based Drug Discovery in the Spotlight: Emerging Trends in Hit Identification and Lead Optimization
Sponsor
Strategic Partnerships In Drug DiscoveryHow Strategic Partnerships Revolutionize Pharma R&D
Sponsor
Integrated Drug DiscoveryAI/ML Integration in the Discovery and Development of Next-Generation Therapeutics
Sponsor
Roundtable Tracks
3Emerging Challenges in Machine Learning (ML) -Driven Molecular Property Predictions
Sponsor
DMPK / ADME & ToxicologyOptimizing Drug Development through Pharmacokinetic Prediction for Enhanced Drug Efficacy
Sponsor
Chemical Biology, Targeted Protein Degradation And UndruggablesChemoproteomics: Probing Small Molecules’ Interactions with Complex Biological Systems
Sponsor
Target Identification To Lead OptimizationFragment Based Drug Discovery in the Spotlight: Emerging Trends in Hit Identification and Lead Optimization
Sponsor
Strategic Partnerships In Drug DiscoveryHow Strategic Partnerships Revolutionize Pharma R&D
Sponsor
Integrated Drug DiscoveryAI/ML Integration in the Discovery and Development of Next-Generation Therapeutics
Sponsor
Roundtable Tracks
4The Evolution of AI: Looking Back at the Past 10 years and Projecting the Future 10
-Rahul Mittal
Head Strategy and Innovation- North America
Dr. Reddy’s Laboratories
DMPK / ADME & Toxicology
Developments in Predictive Modeling and Metabolic Profiling for Advancing Drug Discovery with DMPK
-Herve Aloysius
Head of DMPK
BioCryst Pharmaceuticals
Chemical Biology, Targeted Protein Degradation And Undruggables
Emerging “Undruggable” Targets in Targeted Protein Degradation (Topic TBC)
-Marcie Glicksman
Vice President, Biology
Enclear Therapies
Target Identification To Lead Optimization
Using Computational Methods to Improve Precision and Efficiency in Lead Optimization and Hit Identification
-Rui Wu
Senior Vice President,Head of Research & Preclinical and ChiefCMC Officer
Graviton Bioscience
Strategic Partnerships In Drug Discovery
Collaborative Chemistry: The Business of Partnerships in Drug Innovation
-Gurdyal Kalsi
Chief Medical Officer
Asklepion Pharmaceuticals LLC
Integrated Drug Discovery
The Next Frontier in Therapeutic RNA: Exploring Computational and AI-Driven Approaches for Target Identification, mRNA Synthesis, and Small Molecule Integration (Topic TBC)
-Sesha Kumar
Vice President & Head Intellectual Property, Innovation
Dr. Reddy’s
Roundtable Tracks
5Generative Chemistry in Action: Applications, Challenges, and Breakthroughs
-Shah Nawaz
Chief Technology Officer and Vice President, Digital Technology & Engineering
Regeneron
DMPK / ADME & Toxicology
Strategies to Optimize ADME Properties in Drug Discovery to Enhance Drug Bioavailability
-Sekhar Surapaneni
Executive Director, DMPK
Nimbus Therapeutics
Chemical Biology, Targeted Protein Degradation And Undruggables
From Discovery to Application: Challenges in Using Chemical Probes for Degrader Development (Topic TBC)
-Vikram Sinha
Global Head, Therapeutic Areas
NIBR
Target Identification To Lead Optimization
AI-Driven Drug Discovery: Transforming Hit Identification and Lead Optimization (Topic TBC)
-Joshi Ramanjulu
Chief Scientific Officer
Apogee Pharmaceuticals
Strategic Partnerships In Drug Discovery
The Role of Venture Partnerships in Drug Discovery (Topic TBC)
-Gunaretnam Rajagopal
Venture Partner
Samsara Biocapital
Integrated Drug Discovery
Blood-Brain Barrier Penetration in Drug Discovery: Challenges, Innovations, and Future Directions
-Tanweer Khan
Senior Director, Head of Discovery Chemistry
aTai Life Sciences
Reasons To Attend Our Strategy Meetings

Fully Interactive Format
There's only so much you can learn from presentations and lectures. Instead our interactive Roundtable Discussions let you debate the topics that really matter

Senior Decision Makers
All our Strategy Meetings are aimed at director level and above. Discover how your peers are tackling the industries biggest challenges and have your thoughts heard

Personalised Agendas
Pick the roundtable discussions that you want to be part of. Simply choose your sessions and we'll create a personalised agenda just for you

Private and Intimate Networking
Small group discussions, private meetings, networking drinks - however you choose to make those important connections our Strategy Meetings have the solution
Become an official strategy meeting partner
Whatever your business needs, we can help. Get in touch for partnering opportunitiesExplore Highlight From The Past Events
Gain valuable insights, discover innovative solutions and connect with industry leaders through snapshots of our most successful gatherings.
Press play to hear what your colleagues had to say...

Hotel & Venue
Hyatt Regency Princeton
Hyatt Regency Princeton hotel is conveniently located near corporate offices and attractions, as well as the Mercer County Airport.
Hotel Details Map & Directions Parking




Want to find out more?
Find out more details about our Strategy Meetings and other news and events.
Here To Help
Want to know more? Interested in sponsoring the event? Need help registering your team? Just get in touch and a member of the team will be happy to help.